TAMPA, Florida – TruPharma, LLC (TruPharma) announced today that it has launched a Dapsone 5% Topical Gel product on the TruPharma label. Acrux DDS developed the FDA-approved product and it is the first launch resulting from a multi-product exclusive sales, marketing and distribution agreement entered into between Acrux and TruPharma in 2020.